Table 1.
The relationship of lncRNA OTUD6B-AS1 expression levels (-ΔCt) in cancer tissue with clinical features in KIRC patients
| Variable | KIRC | Group | χ2 | p-Value | |
|---|---|---|---|---|---|
| Low lncRNA | High lncRNA | ||||
| Sample (n) | 52 | 26 | 26 | – | |
| Median circ | - - −6.0999141 (− 0.169--10.594333) |
– | – | – | |
| Median age (year) | 56.8(35–82) | – | – | 0.693 | 0.405 |
| ≤ 56 | 27(51.9%) | 12 | 15 | ||
| > 56 | 25(48.1%) | 14 | 11 | ||
| Gender | 0.080 | 0.777 | |||
| Male | 31(59.6%) | 15 | 16 | ||
| Female | 21(40.4%) | 11 | 10 | ||
| Clinical stage | 5.026 | 0.025* | |||
| Stage I+ II | 36(69.2%) | 12 | 24 | ||
| Stage III+ IV | 16(38.8%) | 14 | 2 | ||
| Tumor stage | 13.000 | 0.000* | |||
| T1+ T2 | 39(75.0%) | 16 | 23 | ||
| T3+ T4 | 13(25.5%) | 10 | 3 | ||
| Lymph node metastasis | 4.591 | 0.032* | |||
| N0 | 37(71.6%) | 15 | 22 | ||
| N1 | 15(28.4%) | 11 | 4 | ||
| NX | – | – | – | ||
| Distant metastasis | 4.127 | 0.042* | |||
| M0 | 45(86.5%) | 20 | 25 | ||
| M1 | 7(13.5%) | 6 | 1 | ||
| MX | – | – | – | ||
| Staus | 0.002* | ||||
| Dead | 25(48.1%) | 17 | 6 | 9.433 | |
| Alive | 27(51.9) | 9 | 20 | ||
Low/high by the sample mean. Pearson χ2-test. p < 0.05 was considered statistically significant